Xin-Hui Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xin-Hui Zhang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Li-Ying Ma
State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Pharmaceutical Technology, Ministry of Education of China, School of Pharmaceutical Science and Institute of Pharmaceutical Science, Zhengzhou University, Zhengzhou, Henan 450001, PR China
2 shared publications Bing Zhao
State Key Laboratory of Esophageal Cancer Prevention and Treament, Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Pharmaceutical Research and School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
1 shared publication- De-Quan Yu
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
1 shared publication - Hong-Min Liu
Zhengzhou University
1 shared publication Hongmin Liu
State Key Laboratory of Esophageal Cancer Prevention and Treament, Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Pharmaceutical Research and School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China
1 shared publicationHui-Qin Kang
Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, PR China
1 shared publication
Latest Publications
- 1 June 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 218, 113392
Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity
- 1 June 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 218, 113392
Identification of novel 1,3-diaryl-1,2,4-triazole-capped histone deacetylase 6 inhibitors with potential anti-gastric cancer activity
- Open Access
- 1 January 2021
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (1) , 203-221
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
- 1 January 2021
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 11 (1) , 203-221
Open AccessDiscovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates